McKesson Corporation vs Zoom Video Communications, Inc. — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while Zoom Video Communications, Inc. trades at $97.74 (market cap $27.62B). The key difference: McKesson Corporation is far larger — about 3.9× Zoom Video Communications, Inc.'s market cap, and McKesson Corporation pays a 0.4% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Zoom Video Communications, Inc. for 92 Days on average.
| MCK | ZM | |
|---|---|---|
Market Cap | $108.46B | $27.62B |
Volume | 712,607 | 3,913,188 |
Sector | Health | Technology |
52-Week High | $995.69 | $111.88 |
52-Week Low | $725.17 | $72.72 |
Typical Hold Time | 74 Days | 92 Days |
Enterprise Value | $115.00B | $20.43B |
Dividend Yield | 0.4% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
Zoom Communications (ZM) trades at $94.67, showing minimal daily movement (-0.11%). The stock maintains a bullish technical outlook with strong moving average signals, though oscillators indicate neutral momentum. Fundamentally, ZM demonstrates robust profitability with 77.3% gross margins and 65.19% net income margin, supported by recent earnings beats. The company continues to innovate with AI-powered revenue solutions and maintains significant institutional interest.
With a consensus price target of $118.08 offering 25% upside potential, ZM presents growth opportunities driven by AI integration and strong financial metrics. However, risks include competitive pressures in the communication software space and reliance on international sales growth. The mixed analyst sentiment (38.78% buy vs 55.1% hold) suggests cautious optimism amid solid fundamentals.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →